placebocontrol trial cephalexin therapi ambulatori manag patient cystic fibrosi effect oral administr cephalexin evalu doubleblind placebocontrol crossov studi 17 patient mild moder pulmonari diseas due cystic fibrosi two year fourmonth period cephalexin altern fourmonth placebo period thu patient serv control subject fungal vulvovagin occur two patient cephalexin therapi 2 year studi rate colon mucoid strain pseudomona aeruginosa increas diseas sever deterior patient initi colon p aeruginosa shortterm cours sputum culturespecif antibiot improv cours patient mild moder pulmonari diseas due cystic fibrosi treatment cephalexin decreas frequenc respiratori ill respiratori ill requir antibiot hospit respiratori ill patient initi colon staphylococcu aureu andor haemophilu influenza also reduc colon organ improv weight gain 16 17 patient associ period cephalexin therapi pulmonari function test remain stabl improv 10 14 patient diseas sever improv patient colon p aeruginosa